Results 151 to 160 of about 14,247 (191)
Some of the next articles are maybe not open access.
Vaccination for quality of life: herpes–zoster vaccines
Aging Clinical and Experimental Research, 2019Current vaccination policy in most high-income countries aims to counteract the decline in cell-mediated immunity to varicella zoster virus that occurs with advancing age or immunosuppression. The aim of this review was to describe the burden of illness associated with herpes zoster (HZ) and post-herpetic neuralgia (PHN) risks and their impact on the ...
Pierre-Olivier Lang, Richard Aspinall
openaire +2 more sources
Herpes zoster vaccine: a protection for the elderly.
Annali di igiene : medicina preventiva e di comunita, 2018The Herpes Zoster vaccine is strongly recommended by the World Health Organization to promote healthy aging by preventing the corresponding age- related disease, also named shingles. The disease is due to the endogenous reactivation of Varicella Zoster Virus, the causal agent of chickenpox, that becomes latent at the peripheral nervous system level ...
A. Di Pietro, A. Facciolà., G. Visalli
openaire +2 more sources
Herpes Zoster and Its Prevention by Vaccination
2020Herpes zoster (HZ; shingles) results from reactivation of varicella-zoster virus (VZV) after primary infection as varicella (chicken pox). It affects mainly older adults and people with immunocompromising diseases or treatments. The most common complication is postherpetic neuralgia (PHN), which has significant adverse effects on quality of life and ...
Robert W, Johnson, Myron J, Levin
openaire +2 more sources
Herpes zoster and vaccination: A clinical review
American Journal of Health-System Pharmacy, 2010Herpes zoster, herpes zoster vaccine, and the cost-effectiveness of the vaccine are reviewed.Herpes zoster infection is estimated to affect one in three people during their lifetime. Two thirds of people who develop this disease are over age 60 years. Postherpetic neuralgia (PHN) is the most common complication of herpes zoster, occurring in 10-18% of ...
Erin N, Adams +2 more
openaire +2 more sources
Barriers to the Use of Herpes Zoster Vaccine
Annals of Internal Medicine, 2010The herpes zoster vaccine is the most expensive vaccine recommended for older adults and the first vaccine to be reimbursed through Medicare Part D. Early uptake has been 2% to 7% nationally.To assess current vaccination practices, knowledge and practice regarding reimbursement, and barriers to vaccination among general internists and family medicine ...
Laura P, Hurley +11 more
openaire +2 more sources
Current vaccines for the prevention of herpes zoster
Current Opinion in Ophthalmology, 2018To summarize the recent advances in the prevention of herpes zoster. The recent Food and Drug Administration (FDA) approval of an adjuvanted subunit vaccine may have a significant impact on the prevention of herpes zoster ophthalmicus.There are currently two commercially available vaccines for the prevention of herpes zoster: a live-attenuated vaccine ...
Allister, Gibbons, Anat, Galor
openaire +2 more sources
Evaluation of herpes zoster vaccine programme
Drug and Therapeutics Bulletin, 2018Review of: Amirthalingam G et al. Evaluation of the herpes zoster vaccination programme 3 years after its introduction in England: a population-based study. Lancet 2018; 3: e82-90.
openaire +2 more sources
Recombinant Zoster Vaccine (Shingrix) to Prevent Herpes Zoster
Nursing for Women's Health, 2018Women ages 50 years and older are at risk for herpes zoster, a reactivated virus from varicella zoster virus (chickenpox) that causes a painful vesicular rash and can result in postherpetic neuralgia. It is estimated that one in three adults will be affected by herpes zoster in their lifetime.
Jacqueline R. Sly, Allyssa L. Harris
openaire +2 more sources
Herpes Zoster Vaccine in Older Adults and the Risk of Subsequent Herpes Zoster Disease
JAMA, 2011Approximately 1 million episodes of herpes zoster occur annually in the United States. Although prelicensure data provided evidence that herpes zoster vaccine works in a select study population under idealized circumstances, the vaccine needs to be evaluated in field conditions.To evaluate risk of herpes zoster after receipt of herpes zoster vaccine ...
Hung Fu, Tseng +5 more
openaire +2 more sources
Preventing Herpes Zoster through Vaccination
Ophthalmology, 2008The role of the zoster vaccine in the prevention of herpes zoster and its sequelae, including postherpetic neuralgia (PHN) and herpes zoster ophthalmicus.Wide administration of the herpes zoster vaccine in accordance with the recommendations of the Centers for Disease Control and Prevention Advisory Committee on Immunization Practices (ACIP) will lead ...
openaire +2 more sources